CN Stock MarketDetailed Quotes
300723 ApicHope Pharmaceutical Group
- 19.25
- +2.02+11.72%
Market Closed Jan 6 15:00 CST
8.70BMarket Cap-25.30P/E (TTM)
20.50High18.20Low186.85KlotVolume18.59Open17.23Pre Close357.96MTurnover4.42%Turnover Ratio47.07P/E (Static)451.69MShares30.7952wk High3.99P/B8.14BFloat Cap12.7452wk Low20.68Limit Up422.82MShs Float34.20Historical High13.78Limit Down13.35%Amplitude6.92Historical Low0.21Dividend TTM19.16Avg Price76.44KlotAsk1.09%Div YieldTTM100Lot Size96.36KlotBid
ApicHope Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -32.98%1.24B | -27.90%912.52M | -13.01%622.87M | 9.79%2.5B | 14.55%1.85B | 39.84%1.27B | 38.84%716M | 3.68%2.28B | -2.32%1.61B | -5.04%905.11M |
| Operating revenue | -32.98%1.24B | -27.90%912.52M | -13.01%622.87M | 9.79%2.5B | 14.55%1.85B | 39.84%1.27B | 38.84%716M | 3.68%2.28B | -2.32%1.61B | -5.04%905.11M |
| Other operating revenue | ---- | -8.25%5.7M | ---- | 183.69%14.04M | ---- | 346.39%6.21M | ---- | 29.43%4.95M | ---- | 741.73%1.39M |
| Total operating cost | -24.65%1.21B | -22.33%867.08M | -15.57%514.28M | 14.84%2.3B | 17.48%1.6B | 42.13%1.12B | 39.00%609.09M | 1.26%2.01B | -5.43%1.37B | -5.71%785.5M |
| Operating cost | 18.99%414.96M | 21.06%253.04M | 49.75%150.91M | 58.09%474.58M | 64.23%348.75M | 81.53%209.02M | 92.23%100.78M | -5.73%300.2M | -15.94%212.35M | -17.34%115.15M |
| Operating tax surcharges | -10.30%20.14M | -11.40%13.47M | -15.75%7.47M | 37.33%41.74M | 4.55%22.45M | 24.64%15.21M | 16.28%8.86M | -2.09%30.39M | -6.13%21.48M | -12.78%12.2M |
| Operating expense | -58.28%359.42M | -49.47%315.85M | -44.56%216.11M | -10.04%1.12B | -2.70%861.54M | 23.99%625.01M | 30.83%389.79M | -2.56%1.25B | -7.31%885.45M | -10.43%504.07M |
| Administration expense | 5.11%190.97M | -0.70%123.57M | 27.93%65.78M | 53.42%329.41M | 42.31%181.69M | 56.99%124.44M | 36.37%51.42M | 27.00%214.71M | 27.01%127.67M | 35.93%79.27M |
| Financial expense | 67.81%22.89M | 48.06%18.52M | 13.48%11.49M | 50.68%32.71M | 630.06%13.64M | 163.41%12.51M | 22.72%10.13M | -43.19%21.71M | -86.04%1.87M | -20.85%4.75M |
| -Interest expense (Financial expense) | 326.04%25.52M | 17.48%20.89M | 20.84%12.31M | 30.02%37.65M | -63.77%5.99M | 30.36%17.78M | 53.45%10.18M | -24.79%28.96M | -6.87%16.54M | 43.15%13.64M |
| -Interest Income (Financial expense) | 68.63%-2.94M | 61.46%-2.31M | -15.84%-1.47M | -38.45%-11.71M | -28.73%-9.38M | -129.07%-6M | 25.28%-1.27M | -13.41%-8.46M | -30.22%-7.28M | 27.84%-2.62M |
| Research and development | 13.64%200.74M | 9.51%142.64M | 29.94%62.53M | 58.80%301.37M | 50.76%176.65M | 85.89%130.25M | 40.53%48.12M | 33.34%189.78M | 17.57%117.18M | 33.13%70.07M |
| Credit Impairment Loss | 377.98%2.34M | 379.89%2.35M | ---- | -63.10%-3.5M | 105.60%489.84K | 106.05%489.84K | ---- | -203.34%-2.15M | --238.25K | --237.72K |
| Other net revenue | -191.02%-21.57M | -111.46%-2.06M | -69.90%5.6M | 85.81%13.8M | 665.89%23.69M | -1.69%18.01M | 266.30%18.6M | -88.89%7.43M | -96.82%3.09M | 49.35%18.32M |
| Fair value change income | ---- | ---- | ---- | 75.53%-3.05M | ---- | ---- | ---- | -152.04%-12.47M | ---- | ---- |
| Invest income | -782.49%-39.65M | -259.00%-20.68M | 1,484.62%731.4K | -36.24%-21.58M | 53.50%-4.49M | 41.39%-5.76M | -105.89%-52.82K | -173.70%-15.84M | -309.83%-9.66M | -492.20%-9.83M |
| -Including: Investment income associates | -557.30%-46.18M | -221.70%-22.6M | ---- | 2.89%-30.67M | ---7.03M | ---7.03M | ---- | -393.37%-31.58M | ---- | ---- |
| Asset deal income | -318.88%-299.03K | -1,872.11%-303.16K | ---- | -35.63%120.9K | -377.02%-71.39K | -33.62%17.11K | 6,370.31%28.22K | 384.68%187.81K | 5,643.77%25.77K | --25.77K |
| Other revenue | -42.23%16.04M | -28.77%16.57M | -73.87%4.87M | 10.92%41.82M | 122.30%27.77M | -16.57%23.27M | 345.35%18.63M | 70.09%37.7M | -83.13%12.49M | 185.72%27.89M |
| Operating profit | -96.60%9.15M | -74.07%43.38M | -9.02%114.19M | -24.13%213.93M | 6.68%268.79M | 21.29%167.29M | 51.96%125.51M | -1.16%281.97M | -17.66%251.97M | 4.16%137.93M |
| Add:Non operating Income | -99.09%406.41K | -99.21%351.8K | -89.92%173.3K | -5.96%49.3M | -14.92%44.6M | 38.11%44.54M | -66.48%1.72M | -41.42%52.42M | 153.55%52.41M | 505.37%32.25M |
| Less:Non operating expense | 12,244.98%274.67M | 409.58%5.98M | 585.58%2.67M | 138.51%19.04M | -58.68%2.22M | -67.78%1.17M | 36.67%388.86K | -33.45%7.98M | -42.56%5.38M | -2.28%3.64M |
| Total profit | -185.20%-265.11M | -82.08%37.75M | -11.94%111.7M | -25.19%244.19M | 4.07%311.16M | 26.49%210.66M | 45.06%126.84M | -10.02%326.41M | -5.77%299M | 24.26%166.54M |
| Less:Income tax cost | -91.64%4.33M | -67.20%6.72M | -27.86%16.21M | 43.65%92.39M | -0.87%51.8M | -16.94%20.48M | 63.47%22.47M | -7.27%64.32M | -1.17%52.25M | 46.11%24.66M |
| Net profit | -203.89%-269.44M | -83.68%31.03M | -8.52%95.49M | -42.08%151.8M | 5.11%259.36M | 34.04%190.17M | 41.63%104.38M | -10.67%262.1M | -6.69%246.74M | 21.11%141.87M |
| Net profit from continuing operation | -203.89%-269.44M | -83.68%31.03M | -8.52%95.49M | -42.08%151.8M | 5.11%259.36M | 34.04%190.17M | 41.63%104.38M | -10.67%262.1M | -6.69%246.74M | 21.11%141.87M |
| Less:Minority Profit | -1.37%-22.91M | -4.47%-15.42M | 25.33%-5.03M | -14.80%-32.82M | -17.55%-22.6M | -15.98%-14.77M | -10.41%-6.73M | -111.74%-28.59M | 19.48%-19.22M | -1,457.51%-12.73M |
| Net profit of parent company owners | -187.44%-246.54M | -77.33%46.46M | -9.53%100.51M | -36.49%184.61M | 6.01%281.95M | 32.56%204.94M | 39.24%111.11M | -5.29%290.68M | -7.75%265.96M | 31.06%154.6M |
| Earning per share | ||||||||||
| Basic earning per share | -187.44%-0.5458 | -77.32%0.1029 | -9.53%0.2213 | -37.96%0.42 | 6.59%0.6242 | 29.15%0.4537 | -11.57%0.2446 | -37.95%0.677 | -41.64%0.5856 | -14.19%0.3513 |
| Diluted earning per share | -187.44%-0.5458 | -77.32%0.1029 | -9.53%0.2213 | -37.50%0.42 | 6.59%0.6242 | 29.15%0.4537 | -11.57%0.2446 | -38.06%0.672 | -41.64%0.5856 | -14.19%0.3513 |
| Other composite income | ||||||||||
| Total composite income | -203.89%-269.44M | -83.68%31.03M | -8.52%95.49M | -42.08%151.8M | 5.11%259.36M | 34.04%190.17M | 41.63%104.38M | -10.67%262.1M | -6.69%246.74M | 21.11%141.87M |
| Total composite income of parent company owners | -187.44%-246.54M | -77.33%46.46M | -9.53%100.51M | -36.49%184.61M | 6.01%281.95M | 32.56%204.94M | 39.24%111.11M | -5.29%290.68M | -7.75%265.96M | 31.06%154.6M |
| Total composite income of minority owners | -1.37%-22.91M | -4.47%-15.42M | 25.33%-5.03M | -14.80%-32.82M | -17.55%-22.6M | -15.98%-14.77M | -10.41%-6.73M | -111.74%-28.59M | 19.48%-19.22M | -1,457.51%-12.73M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Guangdong Sinong Accounting Firm (Special General Partnership) | -- | -- | -- | Guangdong Sinong Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
